NEWS!
$Nurix Therapeutics(NRIX.US$ Nurix Therapeutics Announces Collaboration With Seagen To Develop A Portfolio Of Degrader-Antibody Conjugates; Co. To Receive $60M Upfront Payment And Potential For $3.4B In Milestones Plus Royalties
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment